...
首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Off-pump vs. on-pump coronary artery bypass surgery: An updated meta-analysis and meta-regression of randomized trials
【24h】

Off-pump vs. on-pump coronary artery bypass surgery: An updated meta-analysis and meta-regression of randomized trials

机译:体外循环与体外循环冠状动脉搭桥手术:随机试验的最新荟萃分析和荟萃回归

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims The benefits of off-pump coronary artery bypass (OPCAB) continue to be debated, in part due to the fact that pooled effects fail to consider differences in trial and patient characteristics. We sought to analyse the contemporary evidence for OPCAB vs. conventional coronary artery bypass (CCAB), incorporating recent larger trials, and adjusting for differences in trials using a technique known as meta-regression. Methods and results We systematically reviewed MEDLINE, EMBASE, and the Cochrane database for published and unpublished randomized trials of OPCAB vs. CCAB in which 30-day or in-hospital clinical outcomes were reported. The outcomes of interest were: all-cause mortality, stroke, and myocardial infarction. In addition to measuring the pooled treatment effects using a random effects meta-analysis model, we measured the effect of selected trial-level factors on the effects observed using the meta-regression technique. Fifty-nine trials were included, encompassing 8961 patients with a mean age of 63.4 and 16 females. There was a significant 30 reduction in the occurrence of post-operative stroke with OPCAB [risk ratio (RR) 0.70, 95 CI: 0.490.99]. There was no significant difference in mortality (RR: 0.90, 95 CI: 0.631.30) or myocardial infarction (pooled RR: 0.89, 95 CI: 0.691.13). In the meta-regression analysis, the effect of OPCAB on all of the clinical outcomes was similar regardless of mean age, proportion of females in the trial, number of grafts per patient, and trial publication date. Conclusion Our meta-analysis incorporating recent trials suggests that there appears to be a beneficial effect of OPCAB on stroke. Moreover, our meta-regression does not support the hypothesis that differences in study populations are responsible for the observed outcomes, although pooled individual patient-data would be better suited to confirm these findings.
机译:目的体外循环冠状动脉旁路移植术(OPCAB)的益处仍在争论中,部分原因是合并的效应未能考虑试验和患者特征的差异。我们试图分析OPCAB与常规冠状动脉搭桥术(CCAB)的当代证据,纳入最近的较大试验,并使用称为Meta回归的技术调整试验的差异。方法和结果我们系统回顾了MEDLINE,EMBASE和Cochrane数据库,以进行已发表和未发表的OPCAB与CCAB的随机试验,其中报道了30天或医院内的临床结局。感兴趣的结果是:全因死亡率,中风和心肌梗塞。除了使用随机效应荟萃分析模型测量合并的治疗效应外,我们还测量了所选试验水平因素对使用荟萃回归技术观察到的效应的效应。包括59个试验,包括8961名平均年龄为63.4岁的患者和16名女性。 OPCAB术后中风发生率显着降低30 [风险比(RR)0.70,95 CI:0.490.99]。死亡率(RR:0.90,95 CI:0.631.30)或心肌梗死(合并RR:0.89,95 CI:0.691.13)均无显着差异。在荟萃回归分析中,无论平均年龄,试验中女性的比例,每例患者的移植物数量和试验发表日期如何,OPCAB对所有临床结果的影响均相似。结论我们的荟萃分析结合了最近的研究表明,OPCAB似乎对中风具有有益作用。此外,尽管汇总的患者个人数据更适合于确认这些发现,但我们的荟萃回归不支持以下假设:研究人群的差异是导致观察到的结果的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号